BR100 Increased By (0.44%)
BR30 Increased By (1.39%)
KSE100 Increased By (0.62%)
KSE30 Increased By (0.61%)
BECO 5.43 Decreased By ▼ -0.06 (-1.09%)
BML 55.69 Decreased By ▼ -1.07 (-1.89%)
BOP 35.38 Increased By ▲ 0.26 (0.74%)
CNERGY 8.20 Increased By ▲ 0.05 (0.61%)
DCL 11.55 Increased By ▲ 0.04 (0.35%)
FCCL 58.36 Increased By ▲ 1.61 (2.84%)
FCSC 5.12 Decreased By ▼ -0.03 (-0.58%)
FFL 17.84 Decreased By ▼ -0.04 (-0.22%)
FNEL 1.25 No Change ▼ 0.00 (0%)
HUMNL 11.07 Decreased By ▼ -0.05 (-0.45%)
KEL 8.75 Increased By ▲ 0.33 (3.92%)
KOSM 6.69 Increased By ▲ 0.11 (1.67%)
MLCF 107.15 Increased By ▲ 3.85 (3.73%)
NBP 201.73 Increased By ▲ 1.55 (0.77%)
PACE 11.30 Increased By ▲ 0.01 (0.09%)
PAEL 44.49 Increased By ▲ 1.02 (2.35%)
PIAHCLA 29.41 Increased By ▲ 1.92 (6.98%)
PIBTL 18.64 Increased By ▲ 0.94 (5.31%)
PPL 247.98 Increased By ▲ 3.66 (1.5%)
PRL 35.29 Decreased By ▼ -0.14 (-0.4%)
PTC 66.14 Increased By ▲ 0.79 (1.21%)
SEARL 95.49 Increased By ▲ 2.17 (2.33%)
SSGC 32.04 Decreased By ▼ -0.90 (-2.73%)
TELE 8.87 Decreased By ▼ -0.04 (-0.45%)
THCCL 66.61 Decreased By ▼ -0.11 (-0.16%)
TPLP 10.57 Decreased By ▼ -0.26 (-2.4%)
TREET 25.30 Increased By ▲ 0.18 (0.72%)
TRG 64.40 Decreased By ▼ -0.50 (-0.77%)
WAVES 10.90 Decreased By ▼ -0.03 (-0.27%)
WTL 1.26 Increased By ▲ 0.01 (0.8%)
Markets

Turkey's lira falls past 8 per dollar; FX, stocks eye 6th week of gains

  • The currency lagged its EM peers, which were on course for a small but sixth straight week of gains thanks to a faltering dollar.
Published December 11, 2020 Updated December 11, 2020 05:57pm
By

The Turkish lira hit a two-week low versus the dollar on Friday on a threat of U.S. sanctions, while emerging market currencies and stocks were set for their sixth straight week of gains on global economic recovery hopes.

The lira weakened 1.5pc to trade past 8.00 per dollar at one point after sources told Reuters the United States is poised to impose sanctions on Turkey over its purchase of Russian S-400 air defence systems last year.

The long-anticipated step, which is likely to infuriate Ankara and severely complicate relations with the incoming administration of President-elect Joe Biden, could be announced any day, the sources said.

The currency was last traded at 7.9717 per dollar.

"The sanctions are expected to target Turkey's Presidency of Defence Industries and its head Ismail Demir, which is on the mild end of the spectrum (not surprising given Trump's reluctance to impose sanctions on Turkey in the past)," Elsa Lignos, RBC Capital Market's global head of FX strategy, wrote in a note.

Lignos added that the lira's negative reaction has been contained, with the decision left pending for Biden who could impose stronger sanctions.

Meanwhile, European Union leaders have agreed to prepare limited sanctions on Turkish individuals over an energy exploration dispute with Greece and Cyprus.

The lira has been among the worst performing EM currencies this year as concerns over depleted foreign reserves and high inflation have overshadowed President Tayyip Erdogan's rhetoric of market-friendly reforms.

The currency lagged its EM peers, which were on course for a small but sixth straight week of gains thanks to a faltering dollar.

The Russian rouble slipped on the day even as Brent crude futures rallied past $50 a barrel. Russia is among the world's top three oil nations.

EU leaders were set to extend economic sanctions imposed on Russia for its intervention in Ukraine by another six months.

Eastern European currencies including the Hungarian forint and Polish zloty fell against the euro which firmed after the European Central Bank unveiled fresh stimulus measures on Thursday broadly in line with expectations.

Meanwhile, Sri Lanka's sovereign dollar bonds fell after rating agency S&P slashed the country's credit rating to "CCC+/C", citing concerns that risks to the island nation's debt servicing capacity have risen.

The MSCI's EM equities index was set to for a 0.6pc weekly gain lifted by record gains for Asian stocks on optimism over faster economic rebound in the region and encouraging COVID-19 vaccine developments.

Comments

Comments are closed for this article.